Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Adaptive Biotechnologies Corp (1HM.BE)

Compare
6.51
+0.02
+(0.25%)
At close: April 17 at 9:52:11 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
178,957
178,957
170,276
185,308
154,344
Cost of Revenue
72,080
72,080
75,553
57,909
49,301
Gross Profit
106,877
106,877
94,723
127,399
105,043
Operating Expense
262,221
262,221
296,329
327,585
314,009
Operating Income
-155,344
-155,344
-201,606
-200,186
-208,966
Net Non Operating Interest Income Expense
2,954
2,954
1,731
-182
1,668
Other Income Expense
-7,205
-7,205
-25,429
--
--
Pretax Income
-159,595
-159,595
-225,304
-200,368
-207,298
Net Income Common Stockholders
-159,492
-159,492
-225,250
-200,191
-207,279
Diluted NI Available to Com Stockholders
-159,492
-159,492
-225,250
-200,191
-207,279
Basic EPS
-1.08
-1.08
-1.56
-1.40
-1.48
Diluted EPS
-1.08
-1.08
-1.56
-1.40
-1.48
Basic Average Shares
147,101.65
147,101.65
144,383.29
142,515.92
140,354.92
Diluted Average Shares
147,101.65
147,101.65
144,383.29
142,515.92
140,354.92
Total Operating Income as Reported
-162,549
-162,549
-227,035
-200,186
-208,966
Total Expenses
334,301
334,301
371,882
385,494
363,310
Net Income from Continuing & Discontinued Operation
-159,492
-159,492
-225,250
-200,191
-207,279
Normalized Income
-152,287
-152,287
-199,821
-200,191
-207,279
Interest Income
14,534
14,534
15,531
4,056
1,668
Interest Expense
11,580
11,580
13,800
4,238
--
Net Interest Income
2,954
2,954
1,731
-182
1,668
EBIT
-148,015
-148,015
-211,504
-196,130
-207,298
EBITDA
-128,759
-128,759
-189,273
-175,210
-193,345
Reconciled Cost of Revenue
54,527
54,527
55,021
38,688
37,047
Reconciled Depreciation
19,256
19,256
22,231
20,920
13,953
Net Income from Continuing Operation Net Minority Interest
-159,492
-159,492
-225,250
-200,191
-207,279
Total Unusual Items Excluding Goodwill
-7,205
-7,205
-25,429
--
--
Total Unusual Items
-7,205
-7,205
-25,429
--
--
Normalized EBITDA
-121,554
-121,554
-163,844
-175,210
-193,345
12/31/2021 - 5/21/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade